idiopathic pulmonary fibrosis program (Vectura)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Nameidiopathic pulmonary fibrosis program (Vectura)
Drug Alias Nameidiopathic pulmonary fibrosis program (Activaero)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsIdiopathic Pulmonary Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryEurope
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesActivaero Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesActivaero GmbhVectura Group Ltd
Active IndicationsN/A
Inactive IndicationsIdiopathic Pulmonary Fibrosis

Other Information

ATC CodeN/A
Related LinksN/A